BABA vs CHPT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.
ChargePoint exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and an alarming Debt/Equity ratio of 12.98. While the Price/Sales ratio is low (0.41), this is offset by catastrophic profitability metrics, including a -277.38% ROE and negative profit margins of -53.55%. The company's long-term price performance is devastating, with a 98.7% decline over five years, and insider sentiment remains bearish with zero buy transactions in the last six months. The combination of high leverage and anemic revenue growth (7.3%) suggests a high risk of insolvency or significant dilution.
Compare Another Pair
Related Comparisons
BABA vs CHPT: Head-to-Head Comparison
This page compares Alibaba Group Holding Limited (BABA) and ChargePoint Holdings, Inc. (CHPT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.